elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38923529-092B1AC8-327B-42D0-916E-8F357F08E655
Q38923529-092B1AC8-327B-42D0-916E-8F357F08E655
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38923529-092B1AC8-327B-42D0-916E-8F357F08E655
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma.
P2860
Q38923529-092B1AC8-327B-42D0-916E-8F357F08E655
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38923529-092B1AC8-327B-42D0-916E-8F357F08E655
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91098a9589d12ae16a20ff2deb61d06b4c8155c6
P2860
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial